7477 related articles for article (PubMed ID: 2424086)
1. Biologic response modifiers as adjuncts to other therapeutic modalities.
Borden EC; Hawkins MJ
Semin Oncol; 1986 Jun; 13(2):144-52. PubMed ID: 2424086
[No Abstract] [Full Text] [Related]
2. Immunotherapy from malignant disease.
Goodnight JE; Morton DL
Annu Rev Med; 1978; 29():231-83. PubMed ID: 348035
[No Abstract] [Full Text] [Related]
3. Immunotherapy of cancer: current status.
Goodnight JE; Morton DL
Prog Exp Tumor Res; 1980; 25():61-88. PubMed ID: 6986637
[No Abstract] [Full Text] [Related]
4. BCG as adjuvant immunotherapy for neoplasia.
Hersh EM; Gutterman JU; Mavligit GM
Annu Rev Med; 1977; 28():489-515. PubMed ID: 324372
[No Abstract] [Full Text] [Related]
5. Experience gained in immunotherapy from the immunopharmacology of BCG leading to a second generation of systemic immunity adjuvants.
Mathe G
Comp Immunol Microbiol Infect Dis; 1980; 3(4):407-32. PubMed ID: 6451350
[No Abstract] [Full Text] [Related]
6. Interferons in the treatment of human cancer.
Kirkwood JM; Ernstoff MS
J Clin Oncol; 1984 Apr; 2(4):336-52. PubMed ID: 6323641
[TBL] [Abstract][Full Text] [Related]
7. Immunochemotherapy of human cancer.
Gutterman JU; Mavligit GM; Reed RC; Hersh EM
Semin Oncol; 1974 Dec; 1(4):409-23. PubMed ID: 4620443
[No Abstract] [Full Text] [Related]
8. BCG, levamisole and transfer factor in the treatment of cancer.
Spitler LE
Prog Exp Tumor Res; 1980; 25():178-92. PubMed ID: 6986631
[No Abstract] [Full Text] [Related]
9. Progress in a desert: oasis or mirage?
Wittes RE
J Natl Cancer Inst; 1988 Mar; 80(1):5-7. PubMed ID: 3276903
[No Abstract] [Full Text] [Related]
10. Multimodal surgical adjuvant therapy for a broad spectrum of tumors in humans.?
Hill GJ; Johnson RO; Metter G; Wilson WL; Davis HL; Grage T; Fletcher WS; Golomb FM; Cruz AB
Surg Gynecol Obstet; 1976 Jun; 142(6):882-92. PubMed ID: 820004
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy of human solid tumors with Bacillus Calmette-Guérin: prolongation of disease-free interval and survival in malignant melanoma, breast, and colorectal cancer.
Gutterman JU; Mavligit GM; Blumenshein G; Burgess MA; McBride CM; Hersh EM
Ann N Y Acad Sci; 1976; 277(00):135-59. PubMed ID: 1069546
[No Abstract] [Full Text] [Related]
12. Immunostimulation before chemotherapy in cancer treatment.
Frati L; Barzi A; Caprino MC; Menconi E; Bonmassar E
Pharmacol Res Commun; 1977 Sep; 9(8):689-99. PubMed ID: 563086
[No Abstract] [Full Text] [Related]
13. [Adjuvant immunotherapy with polyadenylic-polyuridylic acid (Poly A.Poly U) in operable cancer of the breast. Recent results of a controlled therapeutic trial].
Lacour J; Lacour F; Spira A; Michelson M; Petit JY; Delage G; Sarrazin D; Contesso G; Viguier J
Chirurgie; 1984; 110(4):418-24. PubMed ID: 6389040
[No Abstract] [Full Text] [Related]
14. Approaches to the treatment of acute leukemia and lymphoma in adults.
Bodey GP; Rodriguez V
Semin Hematol; 1978 Jul; 15(3):221-61. PubMed ID: 353991
[No Abstract] [Full Text] [Related]
15. Immune modulating therapy in gastrointestinal cancer.
Chachoua A; Green M; Muggia FM
Am J Gastroenterol; 1986 Aug; 81(8):623-8. PubMed ID: 2426941
[No Abstract] [Full Text] [Related]
16. Immune adjuvant therapy in lung cancer.
Holmes EC
Prog Exp Tumor Res; 1980; 25():229-41. PubMed ID: 6986634
[No Abstract] [Full Text] [Related]
17. Chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisone alone or with levamisole or with levamisole plus BCG for malignant lymphoma: a Southwest Oncology Group Study.
Jones SE; Grozea PN; Miller TP; Van Slyck EJ; Balcerzak SP; Costanzi JJ; Morrison FS; Eyre HJ; Fabian CJ; Dabich L
J Clin Oncol; 1985 Oct; 3(10):1318-24. PubMed ID: 3900301
[TBL] [Abstract][Full Text] [Related]
18. Rectal MALT lymphoma associated with ulcerative colitis.
Mangla V; Pal S; Dash NR; Das P; Ahuja V; Sharma A; Sahni P; Chattopadhyay TK
Trop Gastroenterol; 2012; 33(3):225-8. PubMed ID: 23600057
[No Abstract] [Full Text] [Related]
19. [Treatment of malignant lymphoma in childhood].
Hattori T; Ishikawa Y; Nishi M; Nakadate H; Hatae Y; Takeda T
Rinsho Ketsueki; 1985 Jan; 26(1):1-6. PubMed ID: 2582160
[No Abstract] [Full Text] [Related]
20. Combined modality treatment in stage I and II diffuse non-Hodgkin's lymphomas.
Bonadonna G; Valagussa P; Buzzoni R; Bajetta E
Prog Clin Biol Res; 1985; 201():369-74. PubMed ID: 2419921
[No Abstract] [Full Text] [Related]
[Next] [New Search]
